Mesalamine
NDC 70771-1513, Mesalamine, suppository, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1513
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208953
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE1000 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1513-7 | 70771151307 | 5 BLISTER PACK in 1 POUCH (70771-1513-7) / 6 SUPPOSITORY in 1 BLISTER PACK (70771-1513-6) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aa63b4bb-2de7-40aa-b26b-1b00b0183eac
Use it
Look up 70771-1513 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1513 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1513. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.